Back to results
US 7,842,782 B2Granted
Heparanase-derived peptides for vaccination of tumor patients
AssigneeDeutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts
InventorsVolker Schirrmacher, Philipp Beckhove, Nora Sommerfeldt
Life of this patent
Estimating the term…
Abstract
Disclosed is a vaccine against diseases, particularly tumor diseases, being associated with an enhanced heparanase expression and/or activity, wherein the vaccine contains a heparanase peptide, which binds to a HLA molecule.
Claims3
A heparanase peptide consisting of SEQ ID No. 1 that binds to a HLA molecule.
A composition comprising a heparanase peptide consisting of SEQ ID No. 1.
Dependencies are inferred from the claim text.